John Kelly
Showing 1–3 of 3 transcripts.
- Milken Institute56 min
Artificial Intelligence Advances, and the Ethical Choices Ahead
Henry Blodgett, Vivian Ming, Pedro Domingos, John Kelly, James Field, Wade
Industry leaders including Pedro Domingos, Vivian Ming, James Field, and John Kelly convened to examine the economic and ethical implications of artificial intelligence, highlighting a shift where routine intellectual tasks face higher automation risks than complex physical labor. The panelists debated the potential for labor market bifurcation and the "Midas problem" of poorly defined AI goals, while acknowledging that hybrid human-machine collaboration currently outperforms standalone systems in fields ranging from chess to medical diagnostics. Addressing future bioethics and consciousness, the group argued that decentralized market forces will likely drive genetic enhancement trends despite ethical concerns, emphasizing the need for transparency and embedded ethical mechanisms rather than universal legislative frameworks.
- Goldman Sachs32 min
Ret. US Marine Corps General and Former White House Chief of Staff John Kelly
General John Kelly outlines a strategic approach to North Korean denuclearization and trade with China that leverages President Trump's deal-making instincts to manage complex international relations despite significant geopolitical hurdles. Simultaneously, the administration is restructuring domestic policies on drug trafficking and border security by advocating for physical barriers, advanced surveillance technology, and comprehensive demand reduction programs to address rising opioid crises and illegal immigration. Kelly asserts that these initiatives operate within an orderly White House environment that prioritizes diverse internal advice while utilizing direct communication channels to bypass traditional media constraints.
- Milken Institute59 min
Why Tomorrow Won't Look Like Today: Things that Will Blow Your Mind
Eric Anderson, John Kelly, Eric David, Richard, Michael, Dr. John Kelly III
Representatives from Planetary Resources, Organovo, and IBM outlined a synergistic future where autonomous asteroid mining provides raw materials, 3D bioprinting creates regenerative medical tissues, and cognitive computing manages the data complexity of both sectors. The panel highlighted specific milestones, including near-term propellant depot launches in 2016, commercial drug-testing liver models, and AI systems designed to personalize cancer treatments. Validated by major investors like Larry Page and Richard Branson, these converging technologies aim to fundamentally transform global resource availability, healthcare outcomes, and the economics of deep-space exploration.